Clinical trial · Observational
Microsampling Approach for Monitoring of Kinase Inhibitor Targeted Therapies
Development of a Microsampling Approach for Personalized Monitoring of Kinase Inhibitor Targeted Therapies
NCT05598788CI-TRIAL-00114651MISTIKcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The MISTIK project aims at clinically validating the technique of oral anticancer drugs determination by volumetric absorptive micro-sampling and at comparing the results to measurements performed on venous samples.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Blood Concentrations of Nine Anti-cancer Drugs : Axitinib, Olaparib, regorafénib, Cabozantinib, Niraparib, Talazoparib, Palbociclib, Abemaciclib, Tucatinib | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Measurement of drug concentrations | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Comparison of venous blood vs VAMS concentrations
- timeFrame
- 1 day
- description
- Comparison of drug concentrations measured from the venous blood samples with concentrations measured from VAMS
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients treated with one of the 9 drugs concerned by the study : axitinib, olaparib, regorafénib, cabozantinib, niraparib, talazoparib, palbociclib, abemaciclib, tucatinib * person who does not object to their participation in the research Exclusion Criteria: * Adults subject to legal protection (safeguard of justice, curatorship, guardianship), persons deprived of their liberty
References
Publications (0)
Data not yet available
No reference posted for this study.